United States-Israel Health Technologies Cooperation Act

• Authority: United States Congress
• Parent authority: Federal government
• Jurisdiction: United States
• Collections: U.S. federal laws
• Most recent activity: Defunct
• Most recent activity date: 2025-01-03

Risk subdomain coverage

All other risk subdomains had no coverage in this document.

Risk Coverage Summary

This document has minimal to no coverage of AI risk domains. It is a funding authorization bill for bilateral health technology cooperation and does not address AI-specific risks, harms, or governance measures. While it mentions AI as one type of health technology eligible for funding, it does not discuss risks associated with AI development or deployment.

Sector coverage

Good coverage — Comprehensive governance measures or mitigations with clear procedures relating to the sector are explicitly described.

• Health Care & Social Assistance

Minimal coverage — Brief mention but no specific mitigations, recommendations or governance measures relating to the sector are described.

• Scientific Research & Development Services

All other sectors had no coverage in this document.

Sectors Summary

This document primarily governs the Health Care and Social Assistance sector by authorizing funding for bilateral development of health technologies including AI. It also has minimal coverage of Scientific Research and Development Services as it funds R&D activities for health technologies.

Legislative Status

Hard Law

Legislative Status Summary

This is a binding legislative instrument (Congressional bill) that authorizes appropriations with specific legal requirements including mandatory matching contributions from Israel. It uses mandatory language and creates legal obligations for fund allocation.

Actors

Proposer

• Entity Types: AI_Governance_Actor
• Entities: United States Congress; Mr. Pappas and co-sponsors
• Summary: The bill was introduced in the House of Representatives by Mr. Pappas and numerous co-sponsors, as indicated in the document header.

Target

• Entity Types: AI_Developer
• Entities: Grant recipients developing health technologies in bilateral US-Israel program
• Summary: The bill targets entities that will receive grants for developing health technologies including AI, through a bilateral cooperative program between the US and Israel.

Enforcer

• Entity Types: AI_Governance_Actor
• Entities: Secretary of Health and Human Services; Secretary of State
• Summary: The Secretary of Health and Human Services is designated as the primary authority for administering the program, with the Secretary of State involved in consultation for new programs.

Monitor

• Entity Types: AI_Governance_Actor
• Entities: Secretary of Health and Human Services
• Summary: While not explicitly stated, the Secretary of Health and Human Services would have oversight responsibility for the bilateral program and grant administration.

AI Lifecycle Stages

Lifecycle stages covered by the documents, as defined in the OECD Framework for the Classification of AI Systems

• Build and Use Model

AI Lifecycle Summary

The document does not specify particular AI lifecycle stages as it is a funding authorization bill. It broadly authorizes grants for development of health technologies including AI, which could encompass multiple lifecycle stages from design through deployment, but does not provide specific governance measures for any particular stage.

Technical Scope

Terms relating to technical scope that are mentioned or implicitly referenced in the document

No technical scope terms identified.

Technical Scope Summary

The document explicitly mentions artificial intelligence as one type of health technology eligible for funding under the bilateral program. It does not define AI or specify particular types of AI systems, models, or technical thresholds. The focus is on health technologies broadly, with AI listed alongside drugs, vaccinations, diagnostic tests, and telemedicine.